Quetiapine: Another Drug With Potential for Misuse? A Case Report
Thomas Paparrigopoulos, MD, PhD; Dimitris Karaiskos, MD; and John Liappas, MD, PhD
J Clin Psychiatry 2008;69(1):162-163 [letter]
© Copyright 2015 Physicians Postgraduate Press, Inc.
To view this item, select one of the options below.
-
-
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
-
Subscribe
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
-
-
Activate
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
-
Sign in
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
-
Click here to login.
-
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.
Sir: The introduction of atypical antipsychotics in the early
1990s opened a new era in the management of schizophrenia
and bipolar disorders.
1 Although not officially approved, some
of these agents have lately been tried for the adjunctive treatment
of substance abuse.
2–5
Several studies suggest that quetiapine may reduce craving
in alcohol-dependent individuals.
3,5–7